Axcella Health Inc. (NASDAQ:AXLA) saw an upside of 11.82% to close Monday at $0.17 after adding $0.01 on the day. The 5-day average trading volume is 823,860 shares of the company’s common stock. It has gained $0.1800 in the past week and touched a new high 2 times within the past 5 days. An average of 315,520 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 363,118.
AXLA’s 1-month performance is -1.85% or -$0.0033 on its low of $0.1500 reached on 08/15/23. The company’s shares have touched a 52-week low of $0.15 and high of $2.70, with the stock’s rally to the 52-week high happening on 01/26/23. YTD, AXLA has lost -46.56% or -$0.1525 and has reached a new high 8 times. However, the current price is down -93.52% from the 52-week high price.
Insider Transactions
AXLA stock investors last saw insider trading activity on Mar 01.Koziel Margaret (Chief Medical Officer) most recently sold 679 shares at $0.58 per share on Mar 01. This transaction cost the insider $394. President & CEO, Hinshaw William, sold 16,000 shares at a price of $1.56 on Oct 19. Then, on Sep 06, Chief Medical Officer Koziel Margaret sold 547 shares at a price of $2.52 per share. This transaction amounted to $1,378.
Valuation Metrics
AXLA stock has a beta of 1.36.
Axcella Health Inc.’s quick ratio for the period ended June 29 was 0.80, with the current ratio over the same period at 0.80. The firm’s gross profit as reported stood at $3.02 million against revenue of $76.99 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income shrunk -524.93% to -$3.41 million, while revenue of -$3.98 million was -16.72% off the previous quarter. Analysts expected AXLA to announce -$0.06 per share in earnings in its latest quarter, but it posted -$0.05, representing a 16.70% surprise. EBITDA for the quarter stood at more than -$3.53 million. AXLA stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 11.54 million, with total debt at $1.39 million. Shareholders hold equity totaling $73.69 million.
Let’s look briefly at Axcella Health Inc. (AXLA) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 21 August was 49.62% to suggest the stock is trending Neutral, with historical volatility in this time period at 85.49%.
The stock’s 5-day moving average is $0.1629, reflecting a +3.55% or $0.0060 change from its current price. AXLA is currently trading -11.17% above its 20-day SMA, -59.88% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -45.31% and SMA200 by-84.16%.
Stochastic %K and %D was 20.04% and 15.77% and the average true range (ATR) pointed at 0.0196. The RSI (14) points at 44.14%, while the 14-day stochastic is at 31.65% with the period’s ATR at 0.0211. The stock’s 9-day MACD Oscillator is pointing at 0.0003 and -0.0077 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Axcella Health Inc. (NASDAQ: AXLA), Noble Capital Markets launched coverage with an Outperform rating. Analysts offering their rating for AXLA stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate AXLA as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 0 have offered a “buy” rating.
What is AXLA’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $1.50 and a high of $1.50, with their median price target at $1.50. Looking at these predictions, the average price target given by analysts is for Axcella Health Inc. (AXLA) stock is $1.50.
